Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19712993 | 0.89 | HTR2C (0.34) | GABRA1GABRB2ALDH1A1CYP3A4SLC6A4 | |
| SCHEMBL10987291 | 0.87 | CYP3A4 (0.44) | GABRA1GABRB2ALDH1A1CYP3A4CYP1A2 | |
| SCHEMBL19712976 | 0.87 | CYP3A4 (0.35) | ALDH1A1CYP3A4CYP1A2HPGD | |
| SCHEMBL28471916 | 0.82 | HPGD (0.43) | GABRA1GABRB2TP53CYP3A4SLC6A4 | |
| SCHEMBL17847448 | 0.82 | CYP3A4 (0.33) | GABRA1GABRB2ALDH1A1CYP3A4SLC6A4 | |
| SCHEMBL17847501 | 0.81 | CYP3A4 (0.41) | LMNATP53ALDH1A1CYP3A4L3MBTL1 | |
| SCHEMBL19712975 | 0.79 | SLC6A4 (0.38) | TP53ALDH1A1CYP3A4NPC1MAPT | |
| SCHEMBL19712969 | 0.78 | PDE7A (0.47) | LMNAL3MBTL1MAPK1SLC6A4SLC6A2 | |
| SCHEMBL19712961 | 0.78 | ALDH1A1 (0.38) | ALDH1A1CYP3A4L3MBTL1CYP1A2MAPT | |
| SCHEMBL624408 | 0.76 | CYP3A4 (0.44) | LMNAALDH1A1CYP3A4L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107223121-B | Wet stable holographic media | 科思创德国股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-3233791-B1 | MOISTURE STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2020-08-12 | — | — | EP | disclosed |
| US-10329244-B2 | Moisture-stable holographic media | COVESTRO DEUTSCHLAND AG (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
| EP-3233791-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | Covestro Deutschland AG (DE) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016096641-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329244-B2 | Moisture-stable holographic media | NEFM, MDM4, BHMT2 | GABRA1 4791/4885GABRB2 4845/4885LMNA 3651/4885 |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | NEFM, MDM4, BHMT2 | GABRA1 4791/4885GABRB2 4845/4885LMNA 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.